A detailed history of Black Rock Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,947,845 shares of KRYS stock, worth $728 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,947,845
Previous 1,805,379 118.67%
Holding current value
$728 Million
Previous $321 Million 125.69%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$153.12 - $183.64 $328 Million - $393 Million
2,142,466 Added 118.67%
3,947,845 $725 Million
Q1 2024

May 10, 2024

SELL
$108.01 - $179.35 $450,185 - $747,530
-4,168 Reduced 0.23%
1,805,379 $321 Million
Q4 2023

Feb 13, 2024

BUY
$96.0 - $128.29 $10.3 Million - $13.8 Million
107,303 Added 6.3%
1,809,547 $224 Million
Q3 2023

Nov 13, 2023

BUY
$108.51 - $130.22 $7.48 Million - $8.98 Million
68,970 Added 4.22%
1,702,244 $197 Million
Q2 2023

Aug 11, 2023

SELL
$78.48 - $130.32 $6.5 Million - $10.8 Million
-82,821 Reduced 4.83%
1,633,274 $192 Million
Q1 2023

May 12, 2023

BUY
$72.39 - $84.27 $1.19 Million - $1.39 Million
16,499 Added 0.97%
1,716,095 $137 Million
Q4 2022

Feb 13, 2023

BUY
$63.14 - $79.9 $8.48 Million - $10.7 Million
134,291 Added 8.58%
1,699,596 $135 Million
Q3 2022

Nov 14, 2022

SELL
$64.85 - $82.4 $8.82 Million - $11.2 Million
-136,017 Reduced 7.99%
1,565,305 $109 Million
Q2 2022

Aug 12, 2022

BUY
$48.93 - $73.47 $871,492 - $1.31 Million
17,811 Added 1.06%
1,701,322 $112 Million
Q1 2022

May 12, 2022

BUY
$51.99 - $72.11 $4.06 Million - $5.63 Million
78,015 Added 4.86%
1,683,511 $112 Million
Q4 2021

Feb 10, 2022

BUY
$39.81 - $88.24 $2.55 Million - $5.66 Million
64,110 Added 4.16%
1,605,496 $112 Million
Q3 2021

Nov 09, 2021

BUY
$52.01 - $71.77 $470,170 - $648,800
9,040 Added 0.59%
1,541,386 $80.5 Million
Q2 2021

Aug 11, 2021

BUY
$62.14 - $81.82 $95.2 Million - $125 Million
1,532,346 New
1,532,346 $104 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.73B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.